OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
January 18, 2023
Author Deepa Purushothaman discusses the progress of women and women of color in corporate America.
Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow.
December 22, 2022
Michael Ku, VP of global clinical supply at Pfizer, shares insights for the c-suite as well as reveals behind-the-scenes insight into Pfizer’s ability to deliver a COVID-19 vaccine swiftly.
November 17, 2022
A clearer understanding of the Inflation Reduction Act’s implications is needed for manufacturers to plot a successful course forward.
October 24, 2022
Rocket Pharmaceutical's CEO and CTO spoke with Pharm Exec about adding a new position to the company's C-suite.
September 16, 2022
Life sciences companies are collaborating more with technology enterprises, universities, and other groups, which is changing the landscape of the industry.
September 08, 2022
Barnes discusses alternative reimbursement plans for expensive, one-off therapies.
August 17, 2022
How pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
July 27, 2022
Corrigan discusses the importance of a patient-centric approach.
July 15, 2022
Patients with Crohn's disease and ulcerative colitis face a high disease burden.